Table 1.
Screening Tests | Confirmatory Tests | Rapid Kit Test | |||||
---|---|---|---|---|---|---|---|
Phenotypic Methods | Genotypic Methods | ||||||
Test Name | Antibiotic | Sensitivity | Test Name | Antibiotic | Sensitivity | ||
Kirby-Bauer disks | Cefotaxime, ceftriaxone, ceftazidime, or aztreonam | 92–93% | Double-disk synergy test (DDST) | Cefotaxime, ceftriaxone, ceftazidime, or aztreonam | 70–80% | PCR | Cica Beta Test 1/HMRZ-86/Chromogenic cephalosporin |
Vitek | Combination disk method, | Cefotaxime and cefepime | 100% | Nucleotide sequencing | |||
E-test ESBL strip | Cefotaxime and ceftazidime | 71–73% | Isoelectric point determination | ||||
Cefepime | 90% | DNA probes | |||||
Oligotyping method | |||||||
PCR-RFLP | |||||||
PCR-SSCP |